Mental Disorders and Quality of Life in Patients With Pulmonary Arterial Hypertension Treated With Sotatercept
ABSTRACT Sotatercept has recently expanded treatment options for pulmonary arterial hypertension (PAH), but its mental health and quality‐of‐life impact is not well characterized. We assessed psychiatric diagnoses and patient‐reported outcomes in PAH patients treated with sotatercept within the clin...
Sábháilte in:
| Príomhchruthaitheoirí: | , , , , , , , , |
|---|---|
| Formáid: | Artigo |
| Teanga: | Inglês |
| Foilsithe / Cruthaithe: |
Wiley
2026-04-01
|
| Sraith: | Pulmonary Circulation |
| Ábhair: | |
| Rochtain ar líne: | https://doi.org/10.1002/pul2.70324 |
| Clibeanna: |
Níl clibeanna ann, Bí ar an gcéad duine le clib a chur leis an taifead seo!
|